Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
Zoladex® clinical trials
2 selected ClinicalTrials.gov records carrying the official matched intervention Zoladex® (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
2 selected records.
1 profiles.
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 30 selected PubMed records and 2 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
ClinicalTrials.gov record NCT00322348
PeptideScanner retained ClinicalTrials.gov record NCT00322348 at 2026-11-15T21:50:32.222Z. Its registry update date was 2011-01-24, and PeptideScanner's reviewed identity mapping was goserelin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- January 24, 2011
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01723774
PeptideScanner retained ClinicalTrials.gov record NCT01723774 at 2026-11-15T21:50:32.222Z. Its registry update date was 2026-09-25, and PeptideScanner's reviewed identity mapping was goserelin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- September 25, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Goserelin · 2026-09-25
ClinicalTrials.gov record NCT01723774
Active, not recruiting at the retained observation.
Open attributed record →Goserelin · 2011-01-24
ClinicalTrials.gov record NCT00322348
Completed at the retained observation.
Open attributed record →